Risk factors for methicillin-resistant Staphylococcus aureus isolation from serially obtained sputum in patients hospitalized with pneumonia

M. Shirata (Kyoto, Japan), I. Ito (Kyoto, Japan), N. Tanabe (Kyoto, Japan), S. Konishi (Kyoto, Japan), I. Oi (Kyoto, Japan), N. Hamao (Kyoto, Japan), S. Imai (Kyoto, Japan), H. Matsumoto (Kyoto, Japan), T. Hirai (Kyoto, Japan)

Source: Virtual Congress 2020 – Clinical challenges in pneumonia
Session: Clinical challenges in pneumonia
Session type: E-poster session
Number: 2033
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Shirata (Kyoto, Japan), I. Ito (Kyoto, Japan), N. Tanabe (Kyoto, Japan), S. Konishi (Kyoto, Japan), I. Oi (Kyoto, Japan), N. Hamao (Kyoto, Japan), S. Imai (Kyoto, Japan), H. Matsumoto (Kyoto, Japan), T. Hirai (Kyoto, Japan). Risk factors for methicillin-resistant Staphylococcus aureus isolation from serially obtained sputum in patients hospitalized with pneumonia. 2033

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
What is MRSA?
Source: Eur Respir J 2009; 34: 1190-1196
Year: 2009



Clinical outcomes of patients with hospital-acquired pneumonia due to community-associated methicillin resistant staphylococcus aureus (CA-MRSA)
Source: Eur Respir J 2007; 30: Suppl. 51, 407s
Year: 2007

Predictive factors for methicillin-resistant Staphylococcus aureus (MRSA) infection in a MRSA screening protocol.
Source: International Congress 2018 – Difficult-to-treat respiratory infections
Year: 2018


Diagnostic challenge in community-acquired pneumonia and hospital-acquired pneumonia: risk factors and diagnostic methods for methicillin resistant Staphylococcus aureus
Source: Annual Congress 2006 - Methicillin resistant Staphylococcus aureus (MRSA): a real hospital-based pathogen?
Year: 2006


Incidence, characteristics and outcomes of patients with severe community acquired-MRSA pneumonia
Source: Eur Respir J 2009; 34: 1148-1158
Year: 2009



Community-associated methicillin-resistant staphylococcus aureus (CA-MRSA) as a cause of hospital-acquired pneumonia (HAP)
Source: Eur Respir J 2007; 30: Suppl. 51, 410s
Year: 2007

An experimental model of pneumonia induced by methicillin-resistant Staphylococcus aureus in ventilated piglets
Source: Eur Respir J 2010; 36: 901-906
Year: 2010



Molecular epidemiology and antimicrobial resistance of methicillin-resistant staphylococcus aureus isolated from nasal swab at intensive care unit
Source: Annual Congress 2008 - Features of hospital-acquired pneumonia, ventilator-associated pneumonia and infection with other pathogens
Year: 2008


MRSA as a cause of lung infection including airway infection, community-acquired pneumonia and hospital-acquired pneumonia
Source: Eur Respir J 2009; 34: 1470-1476
Year: 2009



Prevalence and impact on FEV1 decline of methicillin-resistant Staphylococcus aureus infection in patients with cystic fibrosis
Source: Annual Congress 2011 - Cystic fibrosis: new basic, clinical and bacteriological knowledge
Year: 2011


Community-acquired pneumonia due to S. aureus
Source: Annual Congress 2011 - Aetiology, diagnosis and outcomes in community-acquired pneumonia
Year: 2011

Significance of methicillin-resistant staphylococcus aureus in lower respiratory tract infections
Source: Annual Congress 2008 - Features of hospital-acquired pneumonia, ventilator-associated pneumonia and infection with other pathogens
Year: 2008

Vancomycin MICs for respiratory isolates of community-associated MRSA and hospital-associated MRSA
Source: Annual Congress 2007 - Pulmonary infections in the immunocompetent and immunocompromised host
Year: 2007


Successful eradication of methicillin-resistant staphylococcus aureus in chronically colonized cystic fibrosis patients
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children
Year: 2013


The efficacies of macrolides in a murine model of methicillin-resistant staphylococcus aureus hematogenous pulmonary infection
Source: Eur Respir J 2002; 20: Suppl. 38, 357s
Year: 2002

Detection of alpha-hemolysin in Staphylococcus aureus derived respiratory strains: correlation with microbiological and clinical variables
Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes
Year: 2017

MRSA as a cause of community-acquired pneumonia
Source: Eur Respir J 2009; 34: 1013-1014
Year: 2009


The effect of macrolide-resistance on the outcome of patients hospitalized for streptococcus pneumoniae pneumonia
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015

Antibiotic susceptibility patterns of respiratory strains of Staphylococcus aureus in a Turkish university hospital
Source: Eur Respir J 2003; 22: Suppl. 45, 148s
Year: 2003